Esther Bertrán

3.4k total citations · 1 hit paper
43 papers, 2.3k citations indexed

About

Esther Bertrán is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Esther Bertrán has authored 43 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Hepatology and 15 papers in Oncology. Recurrent topics in Esther Bertrán's work include Liver physiology and pathology (16 papers), TGF-β signaling in diseases (11 papers) and Nitric Oxide and Endothelin Effects (6 papers). Esther Bertrán is often cited by papers focused on Liver physiology and pathology (16 papers), TGF-β signaling in diseases (11 papers) and Nitric Oxide and Endothelin Effects (6 papers). Esther Bertrán collaborates with scholars based in Spain, Italy and United States. Esther Bertrán's co-authors include Isabel Fabregat, Laia Caja, Patricia Sancho, José Luís de la Pompa, Ángel Raya, Luika Timmerman, Sergi Aranda, Juan Díez, Joaquím Grego‐Bessa and Frank McCormick and has published in prestigious journals such as Journal of Biological Chemistry, Genes & Development and Hepatology.

In The Last Decade

Esther Bertrán

43 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation

2003 760 citations Luika Timmerman, Joaquím Grego‐Bessa et al. Genes & Development profile →

Peers

Esther Bertrán

ONCOL

HEPAT

IMMUN

Koichi Hamada Japan

Eliza Wiercinska Germany

Laia Caja Sweden

Changcun Guo China

Yuquan Xiong United States

Mario Mikula Austria

Jinping Lai United States

Béatrice Parfait France

Cédric Coulouarn France

Yoshihiko Kitajima Japan

Koichi Hamada Japan

Esther Bertrán

1.7k ×1.1

536 ×0.8

ONCOL

465 ×1.0

163 ×0.4

HEPAT

520 ×1.7

IMMUN

Citations per year, relative to Esther Bertrán Esther Bertrán (= 1×) peers Koichi Hamada

Countries citing papers authored by Esther Bertrán

Since Specialization

Citations

This map shows the geographic impact of Esther Bertrán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Bertrán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Bertrán more than expected).

Fields of papers citing papers by Esther Bertrán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Bertrán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Bertrán. The network helps show where Esther Bertrán may publish in the future.

Co-authorship network of co-authors of Esther Bertrán

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Bertrán. A scholar is included among the top collaborators of Esther Bertrán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Bertrán. Esther Bertrán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bertrán, Esther, et al.. (2025). New Hepatocellular Carcinoma (HCC) Primary Cell Cultures as Models for Exploring Personalized Anti-TGF-β Therapies Based on Tumor Characteristics. International Journal of Molecular Sciences. 26(6). 2430–2430. 1 indexed citations

Bertrán, Esther, Javier Vaquero, Marina Ruiz de Galarreta, et al.. (2025). New Experimental Mouse Models to Evaluate the Role of Transforming Growth Factor‐Beta in Liver Tumorigenesis. Liver International. 45(10). e70351–e70351. 1 indexed citations

Gonzalez‐Sanchez, Ester, Javier Vaquero, Daniel Caballero‐Díaz, et al.. (2024). The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche. The Journal of Pathology. 263(4-5). 482–495. 8 indexed citations

Alay, Ania, Gabriel Pons, Francesco Dituri, et al.. (2023). Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma. Redox Biology. 65. 102818–102818. 6 indexed citations

Caballero‐Díaz, Daniel, Esther Bertrán, Joaquim Moreno‐Càceres, et al.. (2019). Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer. Journal of Hepatology. 72(1). 125–134. 31 indexed citations

Bertrán, Esther, et al.. (2019). Paradoxical role of the NADPH oxidase NOX4 in early preneoplastic stages of hepatocytes induced by amino acid deprivation. Biochimica et Biophysica Acta (BBA) - General Subjects. 1863(4). 714–722. 4 indexed citations

Malfettone, Andrea, Jitka Soukupová, Esther Bertrán, et al.. (2017). Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. Cancer Letters. 392. 39–50. 75 indexed citations

Crosas‐Molist, Eva, Esther Bertrán, & Isabel Fabregat. (2015). Cross-Talk Between TGF-β and NADPH Oxidases During Liver Fibrosis and Hepatocarcinogenesis. Current Pharmaceutical Design. 21(41). 5964–5976. 32 indexed citations

Caja, Laia, Patricia Sancho, Esther Bertrán, et al.. (2011). The tyrphostin AG1478 inhibits proliferation and induces death of liver tumor cells through EGF receptor-dependent and independent mechanisms. Biochemical Pharmacology. 82(11). 1583–1592. 15 indexed citations

10.

Chisari, A., Patricia Sancho, Laia Caja, Esther Bertrán, & Isabel Fabregat. (2011). Lack of amino acids in mouse hepatocytes in culture induces the selection of preneoplastic cells. Cellular Signalling. 24(1). 325–332. 4 indexed citations

11.

Caja, Laia, Esther Bertrán, Jean S. Campbell, Nelson Fausto, & Isabel Fabregat. (2010). The transforming growth factor‐beta (TGF‐β) mediates acquisition of a mesenchymal stem cell‐like phenotype in human liver cells. Journal of Cellular Physiology. 226(5). 1214–1223. 89 indexed citations

12.

Caja, Laia, Patricia Sancho, Esther Bertrán, & Isabel Fabregat. (2010). Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells. Journal of Hepatology. 55(2). 351–358. 49 indexed citations

13.

Caja, Laia, Patricia Sancho, Esther Bertrán, et al.. (2009). Overactivation of the MEK/ERK Pathway in Liver Tumor Cells Confers Resistance to TGF-β–Induced Cell Death through Impairing Up-regulation of the NADPH Oxidase NOX4. Cancer Research. 69(19). 7595–7602. 99 indexed citations

14.

Bertrán, Esther, Laia Caja, Estanis Navarro, et al.. (2009). Role of CXCR4/SDF-1α in the migratory phenotype of hepatoma cells that have undergone epithelial–mesenchymal transition in response to the transforming growth factor-β. Cellular Signalling. 21(11). 1595–1606. 62 indexed citations

15.

Sancho, Patricia, et al.. (2008). The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-β-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793(2). 253–263. 71 indexed citations

16.

Caja, Laia, et al.. (2006). Differential intracellular signalling induced by TGF-β in rat adult hepatocytes and hepatoma cells: Implications in liver carcinogenesis. Cellular Signalling. 19(4). 683–694. 75 indexed citations

17.

Castillo, Gaelle del, Alberto Álvarez, Esther Bertrán, et al.. (2006). Autocrine production of TGF-β confers resistance to apoptosis after an epithelial–mesenchymal transition process in hepatocytes: Role of EGF receptor ligands. Experimental Cell Research. 312(15). 2860–2871. 66 indexed citations

18.

Timmerman, Luika, Joaquím Grego‐Bessa, Ángel Raya, et al.. (2003). Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes & Development. 18(1). 99–115. 760 indexed citations breakdown →

19.

Pardo, Núria, Francesc Martí, Gloria Fraga, et al.. (1996). High-dose systemic interleukin-2 therapy in stage IV neuroblastoma for one year after autologous bone marrow transplantation: Pilot study. Medical and Pediatric Oncology. 27(6). 534–539. 16 indexed citations

20.

Martí, Francesc, et al.. (1995). Higher cytotoxic activity and increased levels of IL‐1β, IL‐6, and TNF‐α in patients undergoing cardiopulmonary bypass. American Journal of Hematology. 49(3). 237–239. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact